Current Protein & Peptide ScienceCurrent Protein & Peptide ScienceCurrent Protein & Peptide Science1389-20371875-5550Bentham Science64555410.2174/0113892037269116231115065458Life SciencesResearch ArticleMarkers of Oxidative Stress and Tyrosinase Activity in Melasma Patients: A Biochemical InvestigationKatiyarShwetainfo@benthamscience.netYadavDhananjayinfo@benthamscience.netSinghSanjeev K.info@benthamscience.netDepartment of Biochemistry, SBN Govt PG CollegeDepartment of Medical Biotechnology, Yeungnam UniversityDepartment of Biochemistry, GR Medical College,0102202425218318811012025Copyright ©; 2024, Bentham Science Publishers2024Bentham Science Publishershttps://journals.eco-vector.com/1389-2037/article/view/645554

Background:Melasma, oxidative stress, tyrosinase, antioxidants, Homogenized skin tissues, hyperpigmentation disease.

Aims:To compare the levels of oxidative stress and tyrosinase activity in melasma patients with healthy volunteers.

Methods:After written consent, 130 patients were enrolled in a case–control study. 65 cases were of melasma disorder, and 65 were served as control. Homogenized skin tissues were taken and used to estimate superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), glutathione peroxidase (GPx) (antioxidants), malondialdehyde (MDA) and tyrosine hydroxylase (TH).

Results:Melasma patients had lower basal levels of systemic antioxidants than healthy subjects. Tyrosinase activity was shown to be greater in lesional skin than in non-lesional skin. In controls, there was a good positive relationship between TH and MDA and an excellent negative relationship between GPx and GSH. In melasma patients, there were significant associations between CAT, GPx, SOD and MDA.

Conclusions:Increased oxidative stress may affect tyrosinase activity and eumelanin synthesis via the anabolic pathway of melanin synthesis, according to our findings. In conclusion, we discovered a negative relationship between antioxidants and tyrosinase activity.

Melasmaoxidative stresstyrosinaseantioxidantsHomogenized skin tissueshyperpigmentation disease.Ogbechie-Godec, O.A.; Elbuluk, N. Melasma: An up-to-date comprehensive review. Dermatol. Ther. (Heidelb.), 2017, 7(3), 305-318. doi: 10.1007/s13555-017-0194-1 PMID: 28726212Basit, H.; Godse, K.V.; Al Aboud, A.M. Melasma; StatPearls Publications: Treasure Island (FL), 2022.Tomar, A.; Purohit, S.; Gaur, K.; Kaur, M.; Kashyap, A. A case series of 500 melasma cases: A descriptive study. Int Multi J Health, 2017, 3(2), 34-39.Sarkar, R.; Gokhale, N.; Godse, K.; Ailawadi, P.; Arya, L.; Sarma, N.; Torsekar, R.G.; Somani, V.K.; Arora, P.; Majid, I.; Ravichandran, G.; Singh, M.; Aurangabadkar, S.; Arsiwala, S.; Sonthalia, S.; Salim, T.; Shah, S. Medical management of melasma: A review with consensus recommendations by Indian pigmentary expert group. Indian J. Dermatol., 2017, 62(6), 450. doi: 10.4103/ijd.IJD_489_17 PMID: 29263529Sarkar, R.; Ailawadi, P.; Garg, S. Melasma in men a review of clinical, etiological, and management issues. J. Clin. Aesthet. Dermatol., 2018, 11(2), 53-59. PMID: 29552277Sarkar, R.; Ghunawat, S.; Narang, I.; Verma, S.; Garg, V.K.; Dua, R. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma. J. Cosmet. Dermatol., 2019, 18(4), 1066-1073. doi: 10.1111/jocd.12911 PMID: 31033184Nayak, C.S.; Nouveau, S.; Agrawal, D.; Kohli, M.; Bernerd, F.; Misra, N. Skin hyperpigmentation in Indian population: Insights and best practice. Indian J. Dermatol., 2016, 61(5), 487-495. doi: 10.4103/0019-5154.190103 PMID: 27688436Krupa, S.D.S. Melasma/chloasma/mark of pregnancy. Aestheticians J, 2012, 2(1), 7-11.Pichardo, R.; Vallejos, Q. The prevalence of melasma and its association with quality of life among adult male migrant latino workers. Int. J. Dermatol., 2009, 48(1), 22-26. doi: 10.1111/j.1365-4632.2009.03778.x PMID: 19126046Passeron, T.; Picardo, M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res., 2018, 31(4), 461-465. doi: 10.1111/pcmr.12684 PMID: 29285880Jiang, J.; Akinseye, O.; Tovar-Garza, A.; Pandya, A.G. The effect of melasma on self-esteem: A pilot study. Int. J. Womens Dermatol., 2018, 4(1), 38-42. doi: 10.1016/j.ijwd.2017.11.003 PMID: 29872675Aishwarya, K.; Bhagwat, P.V.; John, N. Current concepts in melasma- a review article. J Skin Sexually Trans Dis, 2019, 2(1), 13-17.Hollinger, J.C.; Angra, K.; Halder, R.M. Are natural ingredients effective in the management of hyperpigmentation? A systematic review. J. Clin. Aesthet. Dermatol., 2018, 11(2), 28-37. PMID: 29552273Espósito, A.C.C.; Brianezi, G.; de Souza, N.P.; Miot, L.D.B.; Marques, M.E.A.; Miot, H.A. Exploring pathways for sustained melanogenesis in facial melasma: An immunofluorescence study. Int. J. Cosmet. Sci., 2018, 40(4), 420-424. doi: 10.1111/ics.12468 PMID: 29846953Sonthalia, S.; Sarkar, R. Etiopathogenesis of melasma. Pigment International, 2015, 2(1), 21-27. doi: 10.4103/2349-5847.159389Gutteridge, J.M.C.; Halliwell, B. Mini-Review: Oxidative stress, redox stress or redox success? Biochem. Biophys. Res. Commun., 2018, 502(2), 183-186. doi: 10.1016/j.bbrc.2018.05.045 PMID: 29752940Zainuddin, F.; Anwar, A.I. The Correlation between malondialdehyde serum levels and the duration of sun exposure; and melasma area and severity index in patients with melasma in makassar. Am. J. Clin. Exp. Med., 2016, 4(3), 68-75. doi: 10.11648/j.ajcem.20160403.16Choubey, V.; Sarkar, R.; Garg, V.; Kaushik, S.; Ghunawat, S.; Sonthalia, S. Role of oxidative stress in melasma: A prospective study on serum and blood markers of oxidative stress in melasma patients. Int. J. Dermatol., 2017, 56(9), 939-943. doi: 10.1111/ijd.13695 PMID: 28681382Winterbourn, C.C.; Hawkins, R.E.; Brian, M.; Carrell, R.W. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med., 1975, 85(2), 337-341. PMID: 803541Abei, H. Catalase in vitro. Methods Enzymol., 1984, 105, 121-6.Brehe, J.E.; Burch, H.B. Enzymatic assay for glutathione. Anal. Biochem., 1976, 74(1), 189-197. doi: 10.1016/0003-2697(76)90323-7 PMID: 962073Paglia, D.E.; Valentine, W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 1967, 70(1), 158-169. PMID: 6066618Jean, C.D.; Maryse, T.; Marie, J.F. Plasma malondialdehyde levels during myocardial infarction. Clin. Chim. Acta, 1983, 129, 31922.Kim, M.; Shibata, T.; Kwon, S.; Park, T.J.; Kang, H.Y. Ultraviolet-irradiated endothelial cells secrete stem cell factor and induce epidermal pigmentation. Sci. Rep., 2018, 8(1), 4235. doi: 10.1038/s41598-018-22608-y PMID: 29523807Katiyar, S.; Yadav, D. Correlation of oxidative stress with melasma: An overview. Curr. Pharm. Des., 2022, 28(3), 225-231. doi: 10.2174/1381612827666211104154928 PMID: 34736377Sarkar, R.; Bansal, S. Skin pigmentation in relation to gender: Truth and myth. Pigment International, 2017, 4(1), 1-2. doi: 10.4103/2349-5847.208350Im, S.; Lee, E.S.; Kim, W.; On, W.; Kim, J.; Lee, M.; Kang, W.H. Donor specific response of estrogen and progesterone on cultured human melanocytes. J. Korean Med. Sci., 2002, 17(1), 58-64. doi: 10.3346/jkms.2002.17.1.58 PMID: 11850590Kumre, K.; Varma, K.; Sharma, H.; Singh, U. Study of hormonal profile in female melasma patients in a tertiary care hospital. J. Evol. Med. Dent. Sci., 2016, 5(31), 1663-1666. doi: 10.14260/jemds/2016/392Ertam, I.; Ozkapu, T. Antioxidant activity in melasma. Turkderm-Turk Arch Dermatol Venereol, 2018, 52, 33-36.Zamani, M. Melasma: A brief overview of classification and treatment modalities. In: Aesthetics J; , 2016; 2016, .Hamadi, S.A.; Mohammed, M.M.; Aljaf, A.N.; Ali Abdulrazak, A. The role of topical and oral melatonin in management of melasma patients. J Arab Uni Basic Applied Sci, 2009, 8, 30-32.Seçkin, H.Y.; Kalkan, G.; Baş, Y.; Akbaş, A.; Önder, Y.; Özyurt, H.; Şahin, M. Oxidative stress status in patients with melasma. Cutan. Ocul. Toxicol., 2014, 33(3), 212-217. doi: 10.3109/15569527.2013.834496 PMID: 24147944Kowalczyk, P.; Sulejczak, D.; Kleczkowska, P.; Bukowska-Ośko, I.; Kucia, M.; Popiel, M.; Wietrak, E.; Kramkowski, K.; Wrzosek, K.; Kaczyńska, K. Mitochondrial oxidative stress- a causative factor and therapeutic target in many diseases. Int. J. Mol. Sci., 2021, 22(24), 13384. doi: 10.3390/ijms222413384 PMID: 34948180Xing, X.; Dan, Y.; Xu, Z.; Xiang, L. Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders. Oxid. Med. Cell. Longev., 2022, 2022, 1-12. doi: 10.1155/2022/7881717 PMID: 35087618Conrad, M.; Kagan, V.E.; Bayir, H.; Pagnussat, G.C.; Head, B.; Traber, M.G.; Stockwell, B.R. Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev., 2018, 32(9-10), 602-619. doi: 10.1101/gad.314674.118 PMID: 29802123Salmon, T.B.; Evert, B.A.; Song, B.; Doetsch, P.W. Biological consequences of oxidative stress-induced DNA damage in Saccharomyces cerevisiae. Nucleic Acids Res., 2004, 32(12), 3712-3723. doi: 10.1093/nar/gkh696 PMID: 15254273Babbush, K.; Babbush, R.; Khachemoune, A. The therapeutic use of antioxidants of melasma. J. Drugs Dermatol., 2020, 19(8), 788-792. doi: 10.36849/JDD.2020.5079 PMID: 32845595D’Mello, S.; Finlay, G.; Baguley, B.; Askarian-Amiri, M. Signaling pathways in melanogenesis. Int. J. Mol. Sci., 2016, 17(7), 1144. doi: 10.3390/ijms17071144 PMID: 27428965Kang, H.Y.; Suzuki, I.; Lee, D.J.; Ha, J.; Reiniche, P.; Aubert, J.; Deret, S.; Zugaj, D.; Voegel, J.J.; Ortonne, J.P. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J. Invest. Dermatol., 2011, 131(8), 1692-1700. doi: 10.1038/jid.2011.109 PMID: 21562572